J Orens
Overview
Explore the profile of J Orens including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
11
Citations
217
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Cantu E, Suzuki Y, Diamond J, Ellis J, Tiwari J, Beduhn B, et al.
Am J Transplant
. 2015 Dec;
16(3):833-40.
PMID: 26663441
The authors previously identified plasma plasminogen activator inhibitor-1 (PAI-1) level as a quantitative lung injury biomarker in primary graft dysfunction (PGD). They hypothesized that plasma levels of PAI-1 used as...
2.
Shah R, Diamond J, Cantu E, Flesch J, Lee J, Lederer D, et al.
Am J Transplant
. 2015 Apr;
15(8):2188-96.
PMID: 25877792
Primary graft dysfunction (PGD) is a major cause of early mortality after lung transplant. We aimed to define objective estimates of PGD risk based on readily available clinical variables, using...
3.
Merlo C, Clark S, Arnaoutakis G, Yonan N, Thomas D, Simon A, et al.
Am J Transplant
. 2015 Mar;
15(7):1948-57.
PMID: 25809545
Successful lung transplantation (LTx) depends on multiple components of healthcare delivery and performance. Therefore, we conducted an international registry analysis to compare post-LTx outcomes for cystic fibrosis (CF) patients using...
4.
Shah R, Wickersham N, Lederer D, Palmer S, Cantu E, Diamond J, et al.
Am J Transplant
. 2014 Jan;
14(2):446-52.
PMID: 24400993
Inherent recipient factors, including pretransplant diagnosis, obesity and elevated pulmonary pressures, are established primary graft dysfunction (PGD) risks. We evaluated the relationship between preoperative lung injury biomarkers and PGD to...
5.
Diamond J, Lederer D, Kawut S, Lee J, Ahya V, Bellamy S, et al.
Am J Transplant
. 2011 Sep;
11(11):2517-22.
PMID: 21883907
Primary graft dysfunction (PGD) after lung transplantation may result from ischemia reperfusion injury (IRI). The innate immune response to IRI may be mediated by Toll-like receptor and IL-1-induced long pentraxin-3...
6.
Diamond J, Kawut S, Lederer D, Ahya V, Kohl B, Sonett J, et al.
Am J Transplant
. 2011 Feb;
11(3):561-7.
PMID: 21299834
Primary graft dysfunction (PGD) is the leading cause of early posttransplant morbidity and mortality after lung transplantation. Clara cell secretory protein (CC16) is produced by the nonciliated lung epithelium and...
7.
Hoffman S, Wang L, Shah C, Ahya V, Pochettino A, Olthoff K, et al.
Am J Transplant
. 2009 Jan;
9(2):389-96.
PMID: 19120076
Primary graft dysfunction (PGD) after lung transplantation causes significant morbidity and mortality. We aimed to determine the role of cytokines and chemokines in PGD. This is a multicenter case-control study...
8.
Covarrubias M, Ware L, Kawut S, de Andrade J, Milstone A, Weinacker A, et al.
Am J Transplant
. 2007 Oct;
7(11):2573-8.
PMID: 17908278
Primary graft dysfunction (PGD), a form of acute lung injury occurring within 72 h following lung transplantation, is characterized by pulmonary edema and diffuse alveolar damage. We hypothesized that higher...
9.
Sonett J, Conte J, Orens J, Krasna M
J Heart Lung Transplant
. 1998 May;
17(3):328-30.
PMID: 9563613
Significant airway stenosis occurs in 7% to 14% of lung transplant recipients. The use of permanent, nonadjustable, wire mesh stents can be of concern in the transplant recipient with nonmalignant...
10.